Colfax Corporation [NYSE: CFX] gained 1.44% on the last trading session, reaching $31.63 price per share at the time. The company report on August 6, 2020 that DJO® Revolutionizes the Orthopedic Journey with the Launch of Motion iQ™.
A digital patient relationship management tool that seamlessly connects clinicians and patients across the orthopedic care continuum.
DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get and keep people moving, introduces Motion iQ™, an innovative new software solution designed to transform the surgical journey by connecting the surgeon, care team and patient throughout the continuum of care.
Colfax Corporation represents 136.60 million in outstanding shares, while the company has a total market value of $3.85 billion with the latest information. CFX stock price has been found in the range of $31.03 to $31.96.
If compared to the average trading volume of 1.17M shares, CFX reached a trading volume of 1222674 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Colfax Corporation [CFX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CFX shares is $34.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CFX stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Colfax Corporation shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on May 29, 2020. The new note on the price target was released on May 11, 2020, representing the official price target for Colfax Corporation stock. Previously, the target price had yet another raise to $44, while Goldman analysts kept a Buy rating on CFX stock.
The Average True Range (ATR) for Colfax Corporation is set at 1.11, with the Price to Sales ratio for CFX stock in the period of the last 12 months amounting to 1.11. The Price to Book ratio for the last quarter was 1.31, with the Price to Cash per share for the same quarter was set at 3.00. Price to Free Cash Flow for CFX in the course of the last twelve months was 30.25 with Quick ratio for the last quarter at 1.20.
Trading performance analysis for CFX stock
Colfax Corporation [CFX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.72. With this latest performance, CFX shares gained by 10.67% in over the last four-week period, additionally sinking by -15.36% over the last 6 months – not to mention a rise of 18.60% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CFX stock in for the last two-week period is set at 55.64, with the RSI for the last a single of trading hit 60.43, and the three-weeks RSI is set at 57.53 for Colfax Corporation [CFX]. The present Moving Average for the last 50 days of trading for this stock 29.33, while it was recorded at 30.58 for the last single week of trading, and 30.27 for the last 200 days.
Colfax Corporation [CFX]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Colfax Corporation [CFX] shares currently have an operating margin of +9.77 and a Gross Margin at +42.11. Colfax Corporation’s Net Margin is presently recorded at +0.25.
Return on Total Capital for CFX is now 6.10, given the latest momentum, and Return on Invested Capital for the company is 0.16. Return on Equity for this stock inclined to 0.25, with Return on Assets sitting at 0.12. When it comes to the capital structure of this company, Colfax Corporation [CFX] has a Total Debt to Total Equity ratio set at 72.30. Additionally, CFX Total Debt to Total Capital is recorded at 41.96, with Total Debt to Total Assets ending up at 33.68. Long-Term Debt to Equity for the company is recorded at 70.34, with the Long-Term Debt to Total Capital now at 40.82.
Reflecting on the efficiency of the workforce at the company, Colfax Corporation [CFX] managed to generate an average of $558 per employee. Receivables Turnover for the company is 4.29 with a Total Asset Turnover recorded at a value of 0.48.Colfax Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.90.
Colfax Corporation [CFX]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Colfax Corporation posted 0.5/share EPS, while the average EPS was predicted by analysts to be reported at 0.47/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 6.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CFX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Colfax Corporation go to 6.82%.
An analysis of insider ownership at Colfax Corporation [CFX]
There are presently around $3,736 million, in the hands of institutional investors. The top three institutional holders of CFX stocks are: PRICE T ROWE ASSOCIATES INC /MD/ with ownership of 16,560,767, which is approximately -0.036% of the company’s market cap and around 2.40% of the total institutional ownership; COOKE & BIELER LP, holding 9,412,665 shares of the stock with an approximate value of $297.72 million in CFX stocks shares; and VANGUARD GROUP INC, currently with $259.52 million in CFX stock with ownership of nearly 2.228% of the company’s market capitalization.
Positions in Colfax Corporation stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 134 institutional holders increased their position in Colfax Corporation [NYSE:CFX] by around 17,453,255 shares. Additionally, 126 investors decreased positions by around 13,030,350 shares, while 36 investors held positions by with 87,637,740 shares. The mentioned changes placed institutional holdings at 118,121,345 shares, according to the latest SEC report filing. CFX stock had 32 new institutional investments in for a total of 4,279,321 shares, while 50 institutional investors sold positions of 5,366,604 shares during the same period.